Accel Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-28
Closed -$833 221
2023
Q1
$833 Sell
28
-13
-32% -$377 ﹤0.01% 1189
2022
Q4
$1.11K Buy
41
+13
+46% +$318 ﹤0.01% 958
2022
Q3
$1K Hold
28
﹤0.01% 969
2022
Q2
$1K Hold
28
﹤0.01% 931
2022
Q1
$1K Hold
28
﹤0.01% 897
2021
Q4
$1K Buy
+28
New +$905 ﹤0.01% 900

Other funds holding AVNS

Accel Wealth Management's AVNS Position: Q2 2023 in Review

Accel Wealth Management sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 28 shares — an estimated $833 sold.

Accel Wealth Management first reported a position in AVNS in Q4 2021 and held it in 6 quarters. The position peaked at $1.11K in Q4 2022. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • Accel Wealth Management reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 28 Avanos Medical shares in Q2 2023, an estimated $833.
  • Accel Wealth Management first reported a position in Avanos Medical in Q4 2021 and held it in 6 quarters.
  • Accel Wealth Management's Avanos Medical position peaked at $1.11K in Q4 2022.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.